Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,16288,769,1.80 [1.43-2.26],3.824622951782446e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,15671,236,3.51 [2.45-5.02],6.3519868049609915e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,18366,153,1.60 [0.98-2.61],0.0593638231265366
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,11419,864,2.63 [2.12-3.27],1.480432868593124e-18
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18326,113,1.79 [1.03-3.12],0.039997022401136
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,16355,76,4.03 [2.34-6.95],5.366821424222075e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19512,112,1.79 [1.03-3.13],0.0391556042204579
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19497,74,1.33 [0.65-2.71],0.4317679013483414
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,15945,58,3.52 [1.87-6.63],9.507863929259084e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,18605,109,2.85 [1.73-4.68],3.753519326228554e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,18566,70,3.86 [2.22-6.71],1.6277407829713857e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19592,61,1.90 [0.90-4.01],0.0944014405734515
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19626,55,2.36 [1.13-4.91],0.0219369889312835
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19623,52,2.21 [1.02-4.76],0.043193418819005
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,19224,51,2.35 [1.10-5.02],0.0266571005763159
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",18327,362,2.02 [1.48-2.75],1.07351123577977e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18083,118,2.01 [1.18-3.44],0.0106050263206993
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18227,262,2.01 [1.40-2.89],0.0001682312010401
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",14170,84,1.49 [0.75-2.96],0.2563285175302888
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14134,48,nan [nan-nan],
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",14424,338,0.84 [0.58-1.21],0.3398014589737386
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",14432,346,0.84 [0.59-1.21],0.3580401301611955
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",8141,317,5.32 [3.82-7.39],2.938998004395987e-23
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",6435,173,1.05 [0.64-1.73],0.8392162972996677
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14132,46,4.02 [2.16-7.46],1.0477026069551906e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,16857,614,1.33 [1.03-1.73],0.0279456786514497
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",18325,389,1.17 [0.85-1.61],0.3332186839990323
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19144,129,0.96 [0.55-1.68],0.8793204039973725
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19662,126,1.17 [0.67-2.04],0.5767567208305904
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,19397,79,1.20 [0.59-2.41],0.6133253947388106
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19667,80,1.50 [0.76-2.96],0.2460314738866139
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Stomach,19715,56,1.71 [0.77-3.80],0.1857523443144807
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,19517,240,1.09 [0.73-1.65],0.6683192117507595
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19700,88,0.82 [0.41-1.63],0.569012739600042
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19700,71,0.47 [0.22-1.00],0.0510935324948058
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19629,51,2.00 [0.89-4.47],0.0930808090253267
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma, any site",19632,50,2.05 [0.92-4.59],0.0810048041224338
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi,19579,126,1.33 [0.76-2.31],0.3213531070251985
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,19696,57,1.40 [0.62-3.16],0.4152347517901688
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Other benign neoplasms of skin,19595,143,1.27 [0.75-2.15],0.3648103006290735
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of breast,10370,39,0.42 [0.14-1.24],0.1157341518352316
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Leiomyoma of uterus,10244,262,1.14 [0.76-1.71],0.5236982642229372
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,18431,161,1.96 [1.25-3.10],0.0037159387564809
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,18004,275,1.97 [1.38-2.82],0.0001716807227864
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,18004,275,1.97 [1.38-2.82],0.0001716807227864
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),15888,442,2.74 [2.07-3.63],1.5766390589644234e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19213,49,1.84 [0.79-4.27],0.1543262277822401
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19436,46,1.42 [0.57-3.52],0.4523980893782598
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,14379,1311,1.86 [1.55-2.23],2.348948774746044e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18285,540,0.88 [0.67-1.16],0.3632709628256565
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,17349,117,3.09 [1.90-5.02],5.493568771895953e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18380,135,3.12 [2.00-4.86],5.62893077091242e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17340,108,2.73 [1.61-4.61],0.0001874748294115
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,17862,630,1.89 [1.47-2.42],4.807819156315222e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,17844,612,1.76 [1.36-2.26],1.2910209274349398e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,18184,144,1.88 [1.10-3.23],0.0217382812907835
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",18183,143,1.88 [1.09-3.23],0.0220944661849281
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,14227,1159,1.89 [1.56-2.29],8.34621493021934e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13214,146,3.13 [2.05-4.80],1.511396074355052e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,14143,1075,1.75 [1.43-2.13],4.3414491211497664e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13115,47,4.05 [2.18-7.51],9.05947698543712e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",13145,77,3.59 [2.12-6.05],1.761578128635241e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Any mental disorder,16245,438,1.30 [0.96-1.75],0.0905662424307856
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",15945,138,0.84 [0.49-1.46],0.5411395833849022
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19410,94,0.80 [0.42-1.55],0.514330333904012
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19459,69,0.88 [0.41-1.89],0.7458974494064416
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,18423,32,0.48 [0.16-1.46],0.1964508836462937
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",19653,32,0.50 [0.16-1.50],0.2134548840615261
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",15839,32,0.47 [0.15-1.42],0.1805068075195544
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Alcohol dependence,18429,38,1.08 [0.38-3.02],0.8893744327713381
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Smoking dependency,18372,46,1.15 [0.47-2.84],0.7590643922208505
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15836,29,1.51 [0.51-4.48],0.4593997520320846
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16012,205,1.75 [1.15-2.66],0.0091469837161983
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Depression,18530,182,1.75 [1.12-2.73],0.0142859808637435
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,15730,158,1.55 [0.95-2.52],0.0762551954215915
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",15898,91,1.61 [0.85-3.03],0.1445864050439566
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,18534,55,1.68 [0.75-3.77],0.2048085738041416
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Neurological diseases,16233,1236,1.03 [0.85-1.25],0.7529490284020752
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14268,84,0.52 [0.25-1.09],0.0825361715846173
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19641,62,0.53 [0.23-1.21],0.1328549176779441
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,18632,385,1.33 [0.96-1.83],0.0829931875882838
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Epilepsy,18355,108,0.42 [0.23-0.79],0.0067765957642235
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Migraine,18297,50,0.94 [0.38-2.33],0.8987763693569661
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19526,45,0.88 [0.34-2.29],0.7987463920046145
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18748,97,2.69 [1.57-4.60],0.0003047382657146
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,18376,129,1.64 [0.96-2.81],0.0721255092643726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,19290,96,1.65 [0.89-3.06],0.1123005730234076
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18716,591,0.90 [0.69-1.18],0.4469493686168859
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18210,85,1.67 [0.88-3.18],0.115583033762442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18487,362,0.77 [0.55-1.09],0.1365909736808774
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19412,63,1.80 [0.86-3.77],0.1182246692215532
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hemiplegia,19398,49,1.61 [0.69-3.77],0.2727055668147246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,19262,96,1.07 [0.56-2.04],0.8392322008364902
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",18984,360,0.74 [0.53-1.05],0.0903137687648967
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18843,219,0.71 [0.46-1.10],0.1225146352955538
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18674,50,0.26 [0.11-0.64],0.0033337512102556
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18735,111,0.75 [0.40-1.38],0.3491337629402847
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18712,88,0.92 [0.47-1.83],0.8206900630978375
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,15138,213,1.35 [0.89-2.05],0.1574560041131703
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,15446,521,1.08 [0.82-1.43],0.5904549630867193
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,18537,237,1.91 [1.30-2.79],0.0009009158247505
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19372,49,5.08 [2.81-9.17],6.837865937360605e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2194,49,4.46 [2.26-8.80],1.7053603378597063e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",17227,49,5.41 [2.97-9.84],3.2235024043322114e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,18883,119,1.40 [0.80-2.43],0.2391500569641248
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,18827,63,0.97 [0.44-2.16],0.9474132231730872
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",18953,60,1.22 [0.55-2.73],0.6234251160920907
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19161,79,0.91 [0.44-1.86],0.7898695013165464
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,19643,115,1.28 [0.72-2.29],0.400603743666496
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,18728,97,0.73 [0.38-1.40],0.3373098678239189
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,12142,3736,1.93 [1.69-2.21],1.489326761871326e-21
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,18930,79,2.11 [1.15-3.87],0.0163050593442384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",12927,2590,2.04 [1.75-2.37],9.433651052647512e-21
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertension,12952,2615,2.15 [1.85-2.49],5.58319537271456e-24
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10400,63,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",17304,1469,1.72 [1.45-2.04],3.587025383040921e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,16700,865,1.47 [1.18-1.83],0.000511005478393
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18554,263,1.48 [1.02-2.16],0.0415637376430469
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18844,553,1.65 [1.28-2.14],0.000149034338434
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19574,114,1.66 [0.95-2.92],0.0778211619104866
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16187,352,2.06 [1.50-2.82],8.145968887055608e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,16989,1176,1.74 [1.44-2.10],6.345173439193427e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18745,115,2.66 [1.61-4.41],0.0001367593543654
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,18955,242,1.54 [1.04-2.28],0.0306894573240346
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18740,110,3.19 [1.99-5.11],1.4571039655490009e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18741,111,3.20 [2.00-5.12],1.190053994822496e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10443,106,3.61 [2.22-5.86],2.248956567675911e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14613,61,4.85 [2.78-8.45],2.5287493717961245e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,14686,134,2.43 [1.52-3.89],0.0001978341120354
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7831,112,2.38 [1.42-3.99],0.00098908883676
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,8296,577,2.67 [2.03-3.51],1.61559409998287e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,14629,77,2.38 [1.27-4.46],0.0067126065092355
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,14659,107,4.20 [2.68-6.59],3.93951216621501e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",18365,242,4.42 [3.16-6.19],4.583805227106149e-18
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",18659,158,2.20 [1.40-3.47],0.0006483058229638
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",18686,142,2.42 [1.52-3.85],0.0001884353022517
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",18775,124,2.18 [1.31-3.62],0.0025850563938994
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18359,81,1.19 [0.59-2.39],0.625893995483068
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18423,145,1.84 [1.13-2.99],0.0148814254288051
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18268,144,0.92 [0.54-1.57],0.7669457553452104
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18246,122,1.03 [0.58-1.83],0.9299729102020172
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19477,117,1.16 [0.65-2.06],0.6212733569101234
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Varicose veins,18564,440,0.66 [0.48-0.90],0.0084507661241294
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypotension,18370,97,0.92 [0.48-1.77],0.8007538447064115
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,14603,1835,1.56 [1.33-1.83],2.674362418993421e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19587,70,0.92 [0.43-1.97],0.8303711761815625
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,17613,227,2.95 [2.07-4.20],2.4707672026401406e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",17586,200,2.81 [1.93-4.10],8.183428557364269e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,18669,247,1.95 [1.34-2.83],0.0004588899226308
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,18663,241,1.93 [1.32-2.82],0.0006518724831578
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19100,468,1.08 [0.81-1.46],0.5907873050988317
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18709,77,1.40 [0.69-2.83],0.3519139794776768
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Nasal polyp,18748,116,0.95 [0.52-1.72],0.8578109207018392
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18925,293,1.03 [0.71-1.50],0.8579643976578225
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18750,118,1.16 [0.65-2.08],0.6175393100804423
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6334,65,0.97 [0.43-2.18],0.9451314517821616
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,17052,959,1.26 [1.02-1.55],0.0302035172347277
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Early onset COPD,18334,210,1.62 [1.06-2.46],0.0243720352157732
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",18376,252,1.71 [1.17-2.49],0.0054513936633687
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",18376,252,1.71 [1.17-2.49],0.0054513936633687
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",18255,720,1.21 [0.95-1.53],0.1221426531056345
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Asthma,12879,720,1.32 [1.04-1.69],0.0243778117521734
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",12561,720,1.36 [1.06-1.74],0.0138673666362469
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",12872,713,1.31 [1.03-1.68],0.0290688229663631
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19223,119,2.37 [1.45-3.87],0.0005392411491422
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,18294,93,1.92 [1.07-3.46],0.0298602857009295
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",19297,93,1.90 [1.06-3.42],0.0313196510861764
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18287,86,1.86 [1.00-3.45],0.0487441729179942
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural effusion,17361,121,1.60 [0.92-2.79],0.0977320672736816
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,17487,247,1.92 [1.32-2.79],0.0006832681761281
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,18289,113,2.33 [1.40-3.88],0.0010875627790766
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,12773,5411,1.26 [1.12-1.42],8.250811653794251e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19342,289,1.27 [0.88-1.84],0.1990434027918742
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19720,28,1.64 [0.53-5.07],0.3898482144106273
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impacted teeth,19721,27,1.56 [0.49-4.98],0.4529196488629979
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Dental caries,19140,87,1.87 [1.01-3.48],0.0474251050896273
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19129,76,1.06 [0.51-2.20],0.8718142682309661
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19716,31,1.39 [0.46-4.18],0.5616844152279563
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19136,83,0.73 [0.36-1.49],0.3944854245170776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18904,79,0.93 [0.45-1.92],0.8482349504130724
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19625,52,1.60 [0.70-3.64],0.266090419030018
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14007,278,1.44 [0.99-2.08],0.0541819898984445
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",15880,2151,1.12 [0.96-1.29],0.1456277104753742
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophagitis,14073,344,1.20 [0.85-1.69],0.3040924730120526
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,14443,714,1.14 [0.90-1.46],0.2770432098227291
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,13804,75,1.44 [0.71-2.93],0.3072552799935618
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13968,239,1.52 [1.02-2.27],0.0376970117798568
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13804,75,1.19 [0.58-2.45],0.631013396168361
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,13890,161,1.42 [0.88-2.31],0.1552344698046269
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,13853,124,1.48 [0.86-2.55],0.1576796702968239
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19574,88,0.87 [0.45-1.71],0.6926954001817618
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,13849,120,1.36 [0.77-2.38],0.2875077349286898
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),14538,809,1.15 [0.92-1.44],0.2289750963754599
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,19606,81,1.26 [0.62-2.54],0.520352318186105
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,14127,398,0.98 [0.71-1.35],0.898608772219259
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,13921,192,0.77 [0.48-1.23],0.275911520043669
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19597,102,1.65 [0.92-2.96],0.0952211278942228
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,19594,69,1.25 [0.58-2.67],0.569749165331053
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Hernia,16671,1739,1.14 [0.97-1.34],0.1070867995087518
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,15610,678,1.40 [1.10-1.78],0.0060817172878129
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,15041,109,1.20 [0.66-2.19],0.551544108020205
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ventral hernia,15019,87,1.46 [0.77-2.79],0.2454013226188935
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,15878,946,1.05 [0.85-1.30],0.6271953186210466
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18809,653,1.45 [1.13-1.85],0.0031556350197958
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,14541,1966,1.26 [1.08-1.47],0.0027500472114106
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19423,40,0.32 [0.12-0.88],0.0273727815214101
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",19670,49,0.31 [0.12-0.77],0.0114384512815485
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn disease,18205,49,0.31 [0.12-0.79],0.0134454473884025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18191,35,0.31 [0.10-0.92],0.034787892142015
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",19593,118,1.54 [0.88-2.70],0.12758863055729
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18274,118,1.59 [0.91-2.79],0.1038755555065648
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18265,109,1.76 [0.99-3.12],0.0536760943653537
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18698,542,1.48 [1.13-1.93],0.0043091643178696
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18690,534,1.45 [1.11-1.90],0.0066758353291119
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12684,109,1.36 [0.76-2.44],0.3003579962714042
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal stricture,19228,109,1.30 [0.72-2.34],0.3793475278945672
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12645,70,1.47 [0.72-3.00],0.2959511684758664
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,13331,756,1.22 [0.96-1.54],0.0969034699063377
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12712,137,0.94 [0.54-1.63],0.8141322749998194
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,12840,265,1.50 [1.03-2.19],0.0336317998117569
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Constipation,17997,241,1.35 [0.91-2.02],0.1389538998491958
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19314,72,0.91 [0.43-1.94],0.812747531412801
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12665,90,1.80 [0.98-3.31],0.0567846405615763
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12617,42,1.43 [0.56-3.61],0.4527200864393269
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13398,823,1.25 [1.00-1.56],0.0514776211899539
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,12882,307,1.07 [0.75-1.54],0.7070467523018202
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19301,59,0.68 [0.29-1.57],0.3653403977298649
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of liver,18966,105,2.05 [1.17-3.60],0.0121839128137233
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,18918,57,1.82 [0.83-3.99],0.1345101003686028
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18457,591,1.23 [0.95-1.60],0.1187892952002436
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,18343,477,1.03 [0.77-1.38],0.8519599132732715
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholecystitis,17968,102,1.67 [0.92-3.03],0.0920440631337214
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17910,44,1.56 [0.63-3.86],0.3377007640693116
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,17928,62,1.39 [0.64-3.01],0.4090564516224314
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),19559,62,1.37 [0.63-2.97],0.430914718755898
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,18461,275,1.14 [0.78-1.66],0.5031127271532636
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18242,56,1.04 [0.45-2.43],0.9198128858064756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Coeliac disease,18234,48,1.07 [0.43-2.65],0.8881733064580412
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18230,44,2.05 [0.88-4.78],0.0976509140589987
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18366,180,1.04 [0.65-1.66],0.8812275328167928
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,GI-bleeding,18359,173,1.03 [0.64-1.67],0.891299958365745
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,16619,1360,1.06 [0.88-1.27],0.5485906924066438
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19278,97,1.61 [0.88-2.95],0.1213820967793461
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19376,372,0.86 [0.61-1.20],0.3731689046917925
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18000,524,1.05 [0.79-1.39],0.7318857042181248
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,18836,329,1.37 [0.97-1.93],0.0770402944166194
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18564,57,1.06 [0.46-2.45],0.8877106475971391
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18742,235,1.61 [1.08-2.40],0.0189383830640361
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19447,79,0.97 [0.47-1.98],0.9295443140961446
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19424,56,1.91 [0.88-4.12],0.1001078641996097
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19414,46,2.04 [0.88-4.75],0.0976223642713784
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19357,62,0.87 [0.39-1.98],0.7444297576015284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19356,61,0.83 [0.36-1.90],0.6620962979635272
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19047,43,1.82 [0.75-4.39],0.1826205002736538
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19313,309,0.74 [0.51-1.07],0.1083259555823365
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17572,96,0.69 [0.36-1.35],0.2795327596272943
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17557,81,0.61 [0.29-1.27],0.1885742729479386
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17532,56,1.04 [0.44-2.48],0.92875249061717
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17677,201,0.90 [0.57-1.43],0.6595762757963112
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17663,187,1.00 [0.63-1.60],0.9931205591434776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,12936,3737,1.05 [0.92-1.19],0.4906900006523496
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,14294,2322,0.97 [0.84-1.13],0.6948806811059508
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,17520,1109,1.12 [0.92-1.36],0.27425925246861
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12123,151,1.34 [0.80-2.24],0.2623575619897055
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,12453,481,1.35 [1.01-1.81],0.044242774257795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19283,145,1.34 [0.80-2.24],0.2616361969520937
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19287,133,1.86 [1.12-3.09],0.0158628066106417
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,13329,1357,0.95 [0.78-1.14],0.5591984368218003
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",15494,1357,0.90 [0.75-1.08],0.2466821927573467
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12055,83,6.40 [3.77-10.88],6.5560344618002586e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19090,80,5.71 [3.48-9.36],5.3327412314246586e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,12203,231,0.58 [0.38-0.90],0.0154900309191783
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12071,99,0.74 [0.38-1.44],0.380463365016593
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,12339,367,0.83 [0.59-1.18],0.3050559114652345
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19528,181,0.71 [0.44-1.15],0.1667730145668244
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,12567,595,0.94 [0.72-1.25],0.6851693182297734
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,12431,459,1.20 [0.89-1.63],0.2359894119419364
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13104,1132,0.92 [0.75-1.13],0.4281202899783747
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12054,82,0.54 [0.26-1.12],0.0963900856550599
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12219,247,0.67 [0.44-1.02],0.0643344307154871
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12037,65,1.11 [0.50-2.47],0.801999923112164
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12050,78,0.51 [0.24-1.08],0.0792564146200802
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12353,381,1.34 [0.96-1.86],0.0869510762661582
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12313,341,1.31 [0.92-1.85],0.135942968486756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,14898,234,0.81 [0.53-1.24],0.3281160434750446
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19096,101,0.82 [0.43-1.57],0.5560039737221496
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19056,61,1.57 [0.73-3.34],0.2469697541866409
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16403,69,2.01 [1.02-3.96],0.0436735074258509
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,16651,317,1.05 [0.74-1.51],0.7764296381472666
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,17132,798,1.25 [1.00-1.57],0.0506946307562809
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,16537,203,0.93 [0.59-1.45],0.7334158308421952
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16431,97,1.12 [0.59-2.11],0.7291613039438474
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",16922,588,1.43 [1.11-1.85],0.0063086025439147
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16372,38,0.80 [0.28-2.27],0.6779039489077516
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16512,178,2.19 [1.43-3.34],0.0003144725741103
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16407,73,1.85 [0.92-3.70],0.0831888697093329
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16406,72,1.00 [0.47-2.11],0.997506881054326
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16442,108,1.26 [0.69-2.29],0.4473121962009848
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16388,54,0.68 [0.29-1.63],0.390621345694886
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16574,240,1.55 [1.04-2.29],0.0299947720215505
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16692,281,0.63 [0.43-0.94],0.0234625137806915
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16475,64,0.85 [0.38-1.91],0.69386996131601
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16517,106,0.67 [0.36-1.27],0.2192741559318832
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16481,70,0.50 [0.23-1.11],0.087495634731298
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16446,35,1.37 [0.47-3.96],0.5635666155052691
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16558,147,1.38 [0.83-2.31],0.2129275887293187
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16551,140,1.37 [0.81-2.31],0.2381990766024663
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16662,251,1.24 [0.84-1.84],0.2847931780715244
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16462,51,1.32 [0.56-3.08],0.5220741474266385
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16493,82,1.54 [0.80-2.97],0.1977720061762155
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16527,116,0.71 [0.39-1.29],0.2598158682060963
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16455,44,1.14 [0.44-2.94],0.7924129889318667
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",16796,385,1.37 [1.00-1.89],0.0526732650512761
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16568,157,1.54 [0.95-2.52],0.0815280100291724
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16627,216,1.17 [0.76-1.79],0.4843331847744359
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,17714,208,0.95 [0.61-1.49],0.8350711505796646
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,17870,364,0.95 [0.67-1.33],0.7475065370199436
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17538,32,0.83 [0.26-2.62],0.7539416618954244
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17543,37,1.02 [0.35-2.93],0.974535692941743
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17572,66,0.66 [0.30-1.48],0.3162314963619176
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,14513,3431,1.33 [1.18-1.51],6.807365984060233e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,7558,706,1.14 [0.89-1.46],0.3140200943176898
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,16790,214,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16641,65,3.69 [2.06-6.61],1.1465686319025962e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,16871,45,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,16879,53,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16887,61,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19400,201,2.05 [1.37-3.07],0.0004824122714203
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19245,65,5.57 [3.36-9.21],2.3772755048298048e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19348,149,2.28 [1.45-3.59],0.0003649276057463
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19257,58,2.01 [0.95-4.25],0.0669416935607197
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,17340,1020,1.43 [1.17-1.74],0.0005459141740563
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,16407,87,3.47 [2.07-5.80],2.093690806586756e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16399,79,1.15 [0.56-2.36],0.697261867070973
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16625,305,2.01 [1.44-2.82],4.665624388016812e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16435,115,2.14 [1.27-3.61],0.004185063978512
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,16954,634,1.05 [0.81-1.36],0.7059165617911267
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,7269,417,1.35 [0.98-1.85],0.0638482735403401
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6907,55,1.53 [0.67-3.50],0.3155177961505108
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,6904,52,1.11 [0.46-2.71],0.8134370021618521
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6913,61,0.46 [0.21-1.05],0.0643789085602387
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6928,76,1.78 [0.89-3.59],0.1053270732528854
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6938,86,0.59 [0.30-1.17],0.1336633018551433
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10282,198,1.66 [1.08-2.55],0.0220072750972577
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10148,64,2.53 [1.33-4.81],0.0045453889634769
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,10155,71,1.30 [0.62-2.73],0.4913439624439313
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10135,51,1.11 [0.45-2.76],0.8198013558750322
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10253,144,0.93 [0.54-1.61],0.7938996565421028
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,10156,47,0.94 [0.36-2.45],0.8939184319088314
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10154,45,0.96 [0.36-2.53],0.9336997678035676
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,9519,1568,0.96 [0.80-1.15],0.6252625874169
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,8004,53,0.81 [0.33-2.03],0.6584056634170223
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7994,43,0.85 [0.31-2.35],0.7591084208029577
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8372,421,0.99 [0.72-1.38],0.9652746956745308
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8033,82,1.00 [0.48-2.09],0.9988396640474968
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8354,403,0.82 [0.59-1.16],0.2613694417225738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,8072,121,0.85 [0.46-1.56],0.5927641457843913
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8142,191,0.84 [0.52-1.36],0.4785760867918969
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,7966,15,0.50 [0.09-2.90],0.4402572002414424
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,7990,39,0.90 [0.32-2.59],0.8485190029688451
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",10380,54,0.64 [0.26-1.58],0.3336653055643531
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,10382,49,0.76 [0.29-1.95],0.5619117721264439
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,10387,22,0.71 [0.17-2.86],0.6266090223603231
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",10385,26,0.60 [0.16-2.16],0.4311711683960203
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8019,68,0.57 [0.25-1.29],0.1749655481471009
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,8001,50,2.57 [1.24-5.34],0.0111037417955085
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8013,62,0.55 [0.23-1.29],0.1698054611524645
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,10386,79,0.90 [0.42-1.91],0.7790041429015035
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",8126,175,1.02 [0.61-1.69],0.9469542768050574
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,8032,81,1.45 [0.71-2.96],0.304579602317978
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",10388,35,1.14 [0.38-3.43],0.8126848648185285
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,8049,98,0.85 [0.43-1.69],0.6520601650705177
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7991,40,2.39 [1.01-5.66],0.0471142869016997
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8503,552,0.84 [0.63-1.13],0.2526571289961148
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19271,70,1.55 [0.77-3.15],0.2217603326118344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,16924,554,0.88 [0.67-1.16],0.3738998365906786
